{"schema_version":"secwatch.filing_event.v1","accession":"0001367644-25-000133","form_type":"8-K","ticker":"EBS","cik":"0001367644","company_name":"Emergent BioSolutions Inc.","filed_at":"2025-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.076707+00:00","generated_at":"2026-05-20T13:35:55.225496+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Court grants preliminary approval of $15M derivative suit settlement; final hearing Aug 6","bullets":["Settlement covers five derivative actions alleging breach of fiduciary duty over Bayview vaccine manufacturing failures.","Insurers to pay $15M to Emergent; no admission of fault or liability by any defendant.","Board to adopt corporate governance reforms addressing manufacturing oversight and regulatory compliance.","Final approval hearing scheduled for August 6, 2025 in U.S. District Court for Maryland."],"urls":{"canonical":"https://secwatch.observer/filing/0001367644-25-000133","json":"https://secwatch.observer/filing/0001367644-25-000133.json","markdown":"https://secwatch.observer/filing/0001367644-25-000133.md","text":"https://secwatch.observer/filing/0001367644-25-000133.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000133/0001367644-25-000133-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000133/ebs-20250523.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T13:35:55.225496+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}